ISRCTN12755883已完成1 期
Food effect study of Condrosulf® chondroitin sulfate tablets in healthy male and female volunteers
IBSA Institut Biochimique (Switzerland)0 个研究点目标入组 17 人开始时间: 2022年6月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Signed written informed consent before inclusion in the study
- •2. Men and women aged 30-65 years inclusive
- •3. Body mass index (BMI) of 18.5-30 kg/m2 inclusive
- •4. Systolic blood pressure 100-139 mmHg, diastolic blood pressure 50-89 mmHg, heart rate 50-90 bpm, measured after 5 min at rest in the sitting position
- •5. Ability to comprehend the full nature and purpose of the study, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire study
- •6. Contraception and fertility (women only): women of child-bearing potential must be using at least one of the following reliable methods of contraception:
- •6.1. Hormonal oral, implantable, transdermal, or injectable contraceptives for at least 2 months before the screening visit
- •6.2. A non-hormonal intrauterine device or female condom with spermicide or contraceptive sponge with spermicide or diaphragm with spermicide or cervical cap with spermicide for at least 2 months before the screening visit
- •6.3. A male sexual partner who agrees to use a male condom with spermicide
- •6.4. A sterile sexual partner
- •7. Women of non-child-bearing potential or in post-menopausal status for at least 1 year will be admitted. For all women, pregnancy test result must be negative at screening.
排除标准
- •1. Electrocardiogram (ECG 12-leads, supine position) shows clinically significant abnormalities
- •2. Clinically significant abnormal physical findings which could interfere with the objectives of the study
- •3. Clinically significant abnormal laboratory values indicative of physical illness
- •4. Ascertained or presumptive hypersensitivity to the active principle (chondroitin sulfate) and/or formulations' ingredients or history of anaphylaxis to drugs or allergic reactions in general, which the Investigator considers may affect the outcome of the study
- •5. Significant history of renal, hepatic, gastrointestinal, cardiovascular, respiratory, skin, hematological, endocrine or neurological diseases that may interfere with the aim of the study
- •6. Medications, including over-the-counter medications, herbal remedies and food supplements containing chondroitin sulfate for 2 weeks before the start of the study. Hormonal contraceptives for females will be allowed.
- •7. Participation in the evaluation of any investigational product for 3 months before this study. The 3-month interval is calculated as the time between the first calendar day of the month that follows the last visit of the previous study and the first day of the present study.
- •8. Blood donations for 3 months before this study
- •9. History of drug, alcohol (>1 drink/day for females and >2 drinks/day for males, defined according to the USDA Dietary Guidelines 2020-2025), caffeine (>5 cups coffee/tea/day) or tobacco abuse (10 cigarettes/day)
- •10. Positive result in drug test at screening or Day -3
- •11. Positive alcohol breath test at Day -3
- •12. Abnormal diets (<1600 or >3500 kcal/day) or substantial changes in eating habits in the 4 weeks before this study or vegetarians;
- •13. Pregnancy (women only): positive or missing pregnancy test at screening or Day -3 or pregnant or lactating women
研究者
相似试验
已完成
3 期
Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the KneeJoint DiseasesMuskuloskeletal DiseasesOsteoarthritisSynovitisNCT00604539Bioiberica70
已完成
不适用
Biological reaction by chondroitin sulfate in healthy subjects: randomized, double-blind, placebo-controlled trialJPRN-UMIN000031899Chubu University34
已完成
不适用
Clinical Evaluation of the Effects of Dietary Sulforaphane on Sleep in Healthy VolunteersHealthy adultsJPRN-UMIN000029141Tokai University School of Medicine15
已完成
3 期
Effect of Combined Glucosamine Sulfate and Chondroitin Sulfate Application on Functional Treatment Efficacy of Skeletal Class II MalocclusioSkeletal Class II MalocclusionDRKS00028975Damascus University, Faculty of dental medicine36
已完成
1 期
Safety evaluation and effect of food supplement containing dietary fiber from cassava on the alterations of physiological parameters in overweight female volunteersHealthy conditionsfasting blood sugarHbA1clipid profileatherosclerosis index (AI)TCTR20190521001ational Research Council of Thailand75